![Nataliya Agafonova](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nataliya Agafonova
Hoofd Techniek/Wetenschap/O&O bij LONGEVERON INC.
Vermogen: 1 948 $ op 31-05-2024
Actieve functies van Nataliya Agafonova
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LONGEVERON INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2023 | - |
Loopbaan van Nataliya Agafonova
Eerdere bekende functies van Nataliya Agafonova
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Otsuka Pharmaceutical Development & Commercialization, Inc.
![]() Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 | 01-06-2023 |
BRISTOL-MYERS SQUIBB COMPANY | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Nataliya Agafonova
Bogomolets National Medical University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
2 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
LONGEVERON INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Otsuka Pharmaceutical Development & Commercialization, Inc.
![]() Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
- Beurs
- Insiders
- Nataliya Agafonova
- Ervaring